Population Diagnostics Company
Population Diagnostics is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medicine tests. PDx’s technology, which reveals the genetic causes of complex diseases such as autism, diabetes, Parkinson’s, and Alzheimer’s, enables development of early detection diagnostic tests that predict pre-symptomatically why some individuals will suffer from debilitating diseases while others will live healthy lives.
Industry:
Biomarkers for Longevity
Headquarters:
Melville, New York, United States
Zip:
1-10
Founded Date:
2006-01-01
Employees Number:
1-10
Investors Number:
5360344
Total Funding:
$10M to $50M
Estimated Revenue:
$10M to $50M
Last Funding Date:
Series A
Last Funding Type:
info@populationdiagnostics.com
Register and Claim Ownership